Salivary Phosphate Secretion in Chronic Kidney Disease

Journal of Renal Nutrition

Volumn 18, Issue 1, 2008, Pages 87-90

  Savica, Vincenzo ^a,b   Calò, Lorenzo ^c   Santoro, Domenico ^a   Monardo, Paolo ^b   Granata, Antonio ^a   Bellinghieri, Guido ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Papardo Hospital   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PHOSPHATE;

ADULT; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; REFERENCE VALUE; RENAL REPLACEMENT THERAPY; SALIVA; SECRETION;

ADULT; CALCIUM; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHATES; REFERENCE VALUES; RENAL DIALYSIS; SALIVA;

EID: 37049029168     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2007.10.018     Document Type: Article

References (17)

1. Parfrey P.S. Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant 15 Suppl 5 (2000) 58-68
2. Guerin A.P., London G., Marchais S.J., and Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15 (2000) 1014-1021
3. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
4. Goldsmith D., Ritz E., and Covic A. Vascular calcification: a stiff challenge for the nephrologists. Kidney Int 66 (2004) 1315-1333
5. Burke S.K. Arterial calcification in chronic kidney disease. Semin Nephrol 24 (2004) 403-407
6. Giachelli M.C. Mechanism of vascular calcification in uremia. Semin Nephrol 24 (2004) 401-402
7. Amman K., Tornig J., Kugel B., et al. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 63 (2003) 1296-1301
8. Cozzolino M., Dusso A.S., and Slatopolsky E. Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 12 (2001) 2511-2516
9. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12 (2001) 2131-2138
10. Eknoyan G., Levin A., and Levin N.W. National Kidney Foundation: bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 Suppl 3 (2003) S1-S201
11. Ritz E. Managing mineral balance in end-stage renal disease. Nephrol Dial Transplant 19 Suppl 1 (2004) S1-S3
12. Young E.W., Akiba T., Albert J.M., et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcome and Practice Pattern Study (DOPPS). Am J Kidney Dis 44 (2004) 34-38
13. Lac G. Saliva assays in clinical and research biology. Pathol Biol 49 (2001) 660-667
14. Di Leo R., Vita G., Messina C., and Savica V. Autonomic function in elderly uremics studied by spectral analysis of heart rate. Kidney Int 67 (2005) 1521-1525
15. Kao C.H., Hsiek J.F., Tsai S.C., Ho Y.J., and Chang H.R. Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis 36 (2000) 1140-1144
16. Blum M., Zurkowsky S., Gilard J., and Aviran S. Salivary phosphate and calcium concentration in uremia. Clin Nephrol 12 (1979) 191-192
17. Savica V., Calo' L., Caldarera R., et al. Phosphate salivary secretion in hemodialysis patients: implications for the treatment of hyperphosphatemia. Nephron Physiol 105 (2007) 52-55